RFA
TAK icon

Reyes Financial Architecture’s Takeda Pharmaceutical TAK Stock Holding History

Reyes Financial Architecture’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,670
Closed -$26K – 438
2025
Q4 		$26K Hold
1,670
– – 0.02% 206
2025
Q3 		$24.4K Buy
+1,670
New +$24.8K 0.02% 198

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Reyes Financial Architecture's TAK Position: Q1 2026 in Review

Reyes Financial Architecture sold out of Takeda Pharmaceutical (TAK) in Q1 2026, closing a stake of 1,670 shares — an estimated $26K sold.

Reyes Financial Architecture first reported a position in TAK in Q3 2025 and held it in 2 quarters. The position peaked at $26K in Q4 2025. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Reyes Financial Architecture reported no remaining Takeda Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Reyes Financial Architecture sold 1,670 Takeda Pharmaceutical shares in Q1 2026, an estimated $26K.
  • Reyes Financial Architecture first reported a position in Takeda Pharmaceutical in Q3 2025 and held it in 2 quarters.
  • Reyes Financial Architecture's Takeda Pharmaceutical position peaked at $26K in Q4 2025.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Reyes Financial Architecture's 13F filing for Q1 2026, filed 12 May 2026.